Factors Affecting Dialysis Associated Fatigue
Launched by ASSIUT UNIVERSITY · Nov 3, 2023
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the factors that cause fatigue in patients who are undergoing hemodialysis, a treatment for kidney failure. Researchers want to understand how these factors affect both the physical and emotional well-being of patients. By identifying what contributes to this fatigue, they hope to develop better ways to help patients feel less tired and improve their overall quality of life.
To participate in the trial, you need to be an adult who has been on hemodialysis for at least three months. Unfortunately, those under 18 years old, patients with certain recent kidney issues, or those who cannot provide informed consent due to cognitive challenges will not be eligible. If you do join the study, you can expect to share your experiences related to fatigue, which may help shape future treatments for many patients facing similar challenges. This trial is not yet recruiting participants, but it aims to bring important insights into how we can better support those on hemodialysis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult hemodialysis patients aged ≥ 18 years
- • patients on hemodialysis for at least 3 months
- Exclusion Criteria:
- • patients aged \< 18 years
- • patients with acute kidney injury
- • patients with cognitive impairment or inability to provide informed consent
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported